Cargando…

Transient Cytolysis after Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma

Detalles Bibliográficos
Autor principal:	Rodríguez-Perálvarez, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604559/ https://www.ncbi.nlm.nih.gov/pubmed/36294802 http://dx.doi.org/10.3390/jpm12101663

Ejemplares similares

Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma
por: Nam, Hee Chul, et al.
Publicado: (2016)

Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Tsilimigras, Diamantis I., et al.
Publicado: (2020)

Neutrophil-to-lymphocyte ratio as a prognostic biomarker in hepatocellular carcinoma after transarterial chemoembolization
por: Jeong, Soung Won
Publicado: (2020)

Potential prognostic factors for solitary hepatocellular carcinoma ≤ 5 cm after transarterial chemoembolization
por: Ko, Soon Young, et al.
Publicado: (2019)

Enumeration and Characterization of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Espejo-Cruz, María L., et al.
Publicado: (2023)

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
por: Kloeckner, Roman, et al.
Publicado: (2015)

Radioembolization Followed by Transarterial Chemoembolization in Hepatocellular Carcinoma
por: Vardar, Baran U, et al.
Publicado: (2022)

Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
por: Zhong, Bin-Yan, et al.
Publicado: (2023)

Transarterial chemoembolization for hepatocellular carcinoma in Fontan surgery patient
por: Orlacchio, Antonio, et al.
Publicado: (2020)

Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma
por: Choi, Jonggi, et al.
Publicado: (2020)

Spinal Cord Infarction After Transarterial Chemoembolization for Hepatocellular Carcinoma
por: Lee, Sang-Geun, et al.
Publicado: (2022)

Comparison of the Treatment Response of Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
por: Adel, Hatem, et al.
Publicado: (2023)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
por: Baur, Johannes, et al.
Publicado: (2016)

Repeated transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres vs. conventional transarterial chemoembolization for hepatocellular carcinoma
por: Fukushima, Taito, et al.
Publicado: (2021)

Transarterial Chemoembolization for Hepatocellular Carcinoma: Why, When, How?
por: Kotsifa, Evgenia, et al.
Publicado: (2022)

Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
por: Guo, Yusheng, et al.
Publicado: (2022)

The Current Practice of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
por: Shin, Sung Wook
Publicado: (2009)

Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
por: SHAO, WENBO, et al.
Publicado: (2014)

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
por: Fateen, Waleed, et al.
Publicado: (2017)

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
por: Sacco, Rodolfo, et al.
Publicado: (2017)

Ruptured Massive Hepatocellular Carcinoma Cured by Transarterial Chemoembolization
por: Lee, Ji Eun, et al.
Publicado: (2020)

Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
por: Ahmed, Saleem, et al.
Publicado: (2016)

Effects of transarterial chemoembolization on the immunological function of patients with hepatocellular carcinoma
por: Guo, Jingjing, et al.
Publicado: (2021)

Spontaneous regression of lung metastases after transarterial chemoembolization for hepatocellular carcinoma
por: Kakuta, Naoko, et al.
Publicado: (2021)

Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma
por: Labeur, Tim A., et al.
Publicado: (2018)

Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
por: Jeon, Mi Young, et al.
Publicado: (2019)

Concerns about how to simultaneously determine microvascular invasion and pathological response after transarterial chemoembolization before hepatocellular carcinoma surgery
por: Paik, Kwang Yeol
Publicado: (2023)

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
por: Chung, Jin Wook
Publicado: (2018)

Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer
por: Pocha, Pauline Viviane, et al.
Publicado: (2021)

A simplified model for prophylactic transarterial chemoembolization after resection for patients with hepatocellular carcinoma
por: Lin, Nanping, et al.
Publicado: (2022)

Time-series clustering of cytokine expression after transarterial chemoembolization in patients with hepatocellular carcinoma
por: Qi, Feng, et al.
Publicado: (2020)

Nomogram for predicting pathologic complete response after transarterial chemoembolization in patients with hepatocellular carcinoma
por: Lin, Jian, et al.
Publicado: (2021)

Safety and Efficacy of Transarterial Chemoembolization in Elderly Patients with Intermediate Hepatocellular Carcinoma
por: Roth, Gael S., et al.
Publicado: (2022)

Treatment efficacy and safety of drug-eluting beads transarterial chemoembolization versus conventional transarterial chemoembolization in hepatocellular carcinoma patients with arterioportal fistula
por: Cai, Liang, et al.
Publicado: (2022)

Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization
por: Ventura, Yossi, et al.
Publicado: (2018)

Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma
por: Ha, Yeonjung, et al.
Publicado: (2016)

Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization
por: Fako, Valerie, et al.
Publicado: (2019)

Application of Intravoxel Incoherent Motion in the Evaluation of Hepatocellular Carcinoma after Transarterial Chemoembolization
por: Yue, Xiaofei, et al.
Publicado: (2022)

Hepatocellular Carcinoma: Diagnosis, Treatment Algorithms, and Imaging Appearance after Transarterial Chemoembolization
por: Vande Lune, Patrick, et al.
Publicado: (2018)

Rupture of Hepatocellular Carcinoma after Transarterial Chemoembolization followed by Massive Gastric Bleeding
por: Nishida, Kazuhiro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d8annhas2gst3j0o7idsp9v74c